CTOs on the Move

Regenesis Biomedical Inc

www.amethystinc.com

 
Regenesis Biomedical Inc is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Penumbra

Penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. We design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system. Today we have over 1,300 employees with sales operations in North America, Europe, Latin America, Australia and Asia. Members of the Penumbra team agree that this is where their work has meaning -- we are transforming the treatment of some of the world`s most devastating conditions. Penumbra is where everyone`s ideas matter, and where learning and growth are constant.

BE Medical

BE Medical is a Kendall Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biotage

Biotage is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Microcopy Dental

Since its inception in 1970, Microcopy has been at the forefront in the design and development of diamond and carbide burs for the dental industry. Our NeoDiamond product line—America`s #1 selling diamond—is among the most respected in the dental marketplace. Our team of engineers, marketers and production experts design, package and perform complete product inspections following our ISO-certified quality management system. Because we are a full-service solution for our customers, we are able to provide unparalleled support complete with a 100% performance guarantee. Our mission at Microcopy is to provide a strong sense of satisfaction to each customer by offering truly innovative, effective, high-value products. This combined with a courteous and responsive customer service team is what keeps our loyal customers coming back and inspires them to spread the word about our products to their peers.

Repro Med Systems

Repro-Med Systems, Inc., operating as RMS Medical products, is a leading developer and manufacturer of medical devices and supplies. Repro-Med was incorporated in March, 1980. Its stock is publicly traded in the over-the-counter market and is quoted through the National Daily Quotation Service. Its stock symbol is REPR. The company maintains offices, manufacturing facilities, and warehouse space in Chester, New York. Devices and supplies manufactured and sold by RMS Medical Products are subject to Food and Drug Administration regulation. Our manufacturing facilities and record-keeping must meet FDA standards, and are subject to periodic FDA inspection. In addition, the company's plant is certified by the appropriate ISO international standards for quality in product development, manufacturing, distribution and customer support of its medical devices. RMS manufactures medical devices used in emergency care, hospital settings, nursing homes, other medical facilities and home care. The Company's principal products are the FREEDOM60 Syringe Infusion System and the RES-Q-VAC Emergency Medical Suction System. In 2011, the company received FDA approval to market in the U.S. it's HIgH-Flo RMS Subcutaneous Needle Sets. Since 1986, the company has owned and marketed the Gyneco product line which includes the Masterson Endometrial Biopsy Kit used for in-office biopsy sampling procedures, and the Thermal Cautery System used for tubal ligation procedures. RMS maintains its own sales staff in addition to selling its products through distributors in the U.S. and many other countries. It regularly exhibits at both national and international trade shows. The company holds a number of patents related to products it has developed and is manufacturing. Because Repro-Med Systems, Inc., is a public company, it must comply with financial reporting and other regulations established by the Securities and Exchange Commission.